Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Research Protocols On DTC Brief Summary Info To Be Finalized In Fall

Executive Summary

FDA expects to finalize internal protocols this fall for agency-conducted studies on the brief summary information in direct-to-consumer ads

You may also be interested in...



AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots

AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising

AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots

AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising

FDA DTC Study Should Use Real Ads, Be More Conversational – AstraZeneca

AstraZeneca is asking FDA to incorporate a more qualitative approach in the initial phase of its planned evaluation of the "brief summary" section of direct-to-consumer print advertising

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel